Navigation Links
Avanir Pharmaceuticals Announces Date Of Fiscal 2013 First Quarter Financial Results And Conference Call
Date:1/30/2013

ALISO VIEJO, Calif., Jan. 30, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) will report financial results for the quarter ended December 31, 2012 after market close on Thursday February 7, 2013. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day.

Conference Call Information:
Domestic callers: 1 (866) 783-2141
International callers: +1 (857) 350-1600
Passcode: 51423033

Webcast information: Visit http://www.avanir.com.

A webcast replay will be available on the Avanir Web site for 30 days. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1 (888) 286-8010 for domestic callers, or +1 (617) 801-6888 for international callers, and entering reservation code 87153907.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR® is a registered trademark owned by Avanir Pharmaceuticals, Inc.

©2013 Avanir Pharmaceuticals, Inc. All Rights Reserved.


'/>"/>
SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Avanir Pharmaceuticals Reports Fiscal 2012 Fourth Quarter And Year-End Financial And Business Results
2. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update
3. Avanir Pharmaceuticals To Present At 24th Annual Piper Jaffray Healthcare Conference
4. Avanir Pharmaceuticals Achieves Commercial Milestones & Provides Clinical Updates
5. Avanir Pharmaceuticals To Present At UBS Global Life Sciences Conference
6. Avanir Pharmaceuticals Announces Publication Of PBA Burden Of Illness Study
7. Avanir Pharmaceuticals Announces Enrollment Of First Patient In Study Of AVP-923 For The Treatment Of Agitation In Patients With Alzheimers Disease
8. Avanir Pharmaceuticals To Present At Two Investor Conferences In August
9. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Third Quarter Financial Results And Conference Call
10. Avanir Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
11. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Second Quarter Financial Results And Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... OAKS, Calif. , April 19, 2017 /PRNewswire/ ... industrial buildings it is developing at Conejo Spectrum ... , to Atara Biotherapeutics, Inc. , ... with severe and life-threatening diseases that have been ... on allogeneic T-cell therapies for cancer, autoimmune and ...
(Date:4/18/2017)... DUBLIN , April 18, 2017 Research ... Devices Market 2017-2021" report to their offering. ... The global arthroscopy devices market to grow at ... The report, Global Arthroscopy Devices Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... A new global study ... decade, student well-being has seriously declined. "When disenfranchised youth from the heart of ... Islamic State to turn the historic multi-ethnic and multi-religious powerhouses of the Middle ...
(Date:4/24/2017)... ... April 24, 2017 , ... Miami Periodontist and ... Oral Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and Implant Dentistry held in ... annual Global Symposium at the Fontainebleau Hotel located in Miami Beach, FL. This ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... deionized water from the same place. From 101 Water Texas, here are the ... and staff can enjoy a continuous supply of pure, fresh, oxygenated water, with ...
(Date:4/22/2017)... ... April 22, 2017 , ... ... PROSHRED® Security of Philadelphia its “Woman-Owned Small Business of the Year, ... providing information destruction , recycling, and compliance services to businesses throughout ...
(Date:4/21/2017)... ... 2017 , ... An April 10 article in the Daily Mail ... a great deal about prehistoric ice-age dental practitioners and their primitive and, no doubt, ... remove decayed dental matter, and that teeth were then filled with bitumen, a substance ...
Breaking Medicine News(10 mins):